NEW ARTICLES - Issue in progress
New articles in their final version of record are published here as soon as they are ready, without waiting for the issue contents to be complete. The latest ones are added continuously to the bottom of each section.

Table of Contents

August 2017, Volume 24, Number 8

Review

    • Sangeeta Kumari,
    • Dhirodatta Senapati,
    • and Hannelore V Heemers

    Rationale for the development of alternative forms of androgen deprivation therapy

    Endocr Relat Cancer 24 (8) R275-R295, doi:10.1530/ERC-17-0121 first published on 31 May 2017
    • Nicholas Russell,
    • Ada Cheung,
    • and Mathis Grossmann

    Estradiol for the mitigation of adverse effects of androgen deprivation therapy

    Endocr Relat Cancer 24 (8) R297-R313, doi:10.1530/ERC-17-0153 first published on 30 June 2017

Research

    • Laura C Hernández-Ramírez,
    • Ryhem Gam,
    • Nuria Valdés,
    • Maya B Lodish,
    • Nathan Pankratz,
    • Aurelio Balsalobre,
    • Yves Gauthier,
    • Fabio R Faucz,
    • Giampaolo Trivellin,
    • Prashant Chittiboina,
    • John Lane,
    • Denise M Kay,
    • Aggeliki Dimopoulos,
    • Stephan Gaillard,
    • Mario Neou,
    • Jérôme Bertherat,
    • Guillaume Assié,
    • Chiara Villa,
    • James L Mills,
    • Jacques Drouin,
    • and Constantine A Stratakis

    Loss-of-function mutations in the CABLES1 gene are a novel cause of Cushing’s disease

    Endocr Relat Cancer 24 (8) 379-392, doi:10.1530/ERC-17-0131 first published on 22 May 2017
    OPEN ACCESS ARTICLE
    • Tianzhu Zang,
    • Mary-Ellen Taplin,
    • Daniel Tamae,
    • Wanling Xie,
    • Clementina Mesaros,
    • Zhenwei Zhang,
    • Glenn Bubley,
    • Bruce Montgomery,
    • Steven P Balk,
    • Elahe A Mostaghel,
    • Ian A Blair,
    • and Trevor M Penning

    Testicular vs adrenal sources of hydroxy-androgens in prostate cancer

    Endocr Relat Cancer 24 (8) 393-404, doi:10.1530/ERC-17-0107 first published on 29 June 2017
    • Roberto Valente,
    • Alastair J Hayes,
    • Sven-Petter Haugvik,
    • Per Hedenström,
    • Darko Siuka,
    • Emilie Korsæth,
    • Daniel Kämmerer,
    • Stuart M Robinson,
    • Patrick Maisonneuve,
    • Gianfranco Delle Fave,
    • Bjorn Lindkvist,
    • and Gabriele Capurso

    Risk and protective factors for the occurrence of sporadic pancreatic endocrine neoplasms

    Endocr Relat Cancer 24 (8) 405-414, doi:10.1530/ERC-17-0040 first published on 31 May 2017
    • Praveena S Thiagarajan,
    • Qiao Zheng,
    • Manvir Bhagrath,
    • Erin E Mulkearns-Hubert,
    • Martin G Myers,
    • Justin D Lathia,
    • and Ofer Reizes

    STAT3 activation by leptin receptor is essential for TNBC stem cell maintenance

    Endocr Relat Cancer 24 (8) 415-426, doi:10.1530/ERC-16-0349
    • Jan P Dumanski,
    • Chiara Rasi,
    • Peyman Björklund,
    • Hanna Davies,
    • Abir S Ali,
    • Malin Grönberg,
    • Staffan Welin,
    • Halfdan Sorbye,
    • Henning Grønbæk,
    • Janet L Cunningham,
    • Lars A Forsberg,
    • Lars Lind,
    • Erik Ingelsson,
    • Peter Stålberg,
    • Per Hellman,
    • and Eva Tiensuu Janson

    A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors

    Endocr Relat Cancer 24 (8) 427-443, doi:10.1530/ERC-17-0196 first published on 20 June 2017
    OPEN ACCESS ARTICLE
    • R Formosa,
    • J Borg,
    • and J Vassallo

    Aryl hydrocarbon receptor (AHR) is a potential tumour suppressor in pituitary adenomas

    Endocr Relat Cancer 24 (8) 445-457, doi:10.1530/ERC-17-0112 first published on 25 June 2017
    OPEN ACCESS ARTICLE

Research Letter

    • L Fishbein,
    • S Ben-Maimon,
    • S Keefe,
    • K Cengel,
    • D A Pryma,
    • A Loaiza-Bonilla,
    • D L Fraker,
    • K L Nathanson,
    • and D L Cohen

    SDHB mutation carriers with malignant pheochromocytoma respond better to CVD

    Endocr Relat Cancer 24 (8) L51-L55, doi:10.1530/ERC-17-0086 first published on 31 May 2017
    • Lucie Evenepoel,
    • Raphaël Helaers,
    • Laurent Vroonen,
    • Selda Aydin,
    • Marc Hamoir,
    • Dominique Maiter,
    • Miikka Vikkula,
    • and Alexandre Persu

    KIF1B and NF1 are the most frequently mutated genes in paraganglioma and pheochromocytoma tumors

    Endocr Relat Cancer 24 (8) L57-L61, doi:10.1530/ERC-17-0061 first published on 17 May 2017
    • Frederic Castinetti,
    • Ana Luiza Maia,
    • Mariola Peczkowska,
    • Marta Barontini,
    • Kornelia Hasse-Lazar,
    • Thera P Links,
    • Rodrigo A Toledo,
    • Sarka Dvorakova,
    • Caterina Mian,
    • Maria Joao Bugalho,
    • Stefania Zovato,
    • Maria Alevizaki,
    • Andrei Kvachenyuk,
    • Birke Bausch,
    • Paola Loli,
    • Simona R Bergmann,
    • Attila Patocs,
    • Marija Pfeifer,
    • Josefina Biarnes Costa,
    • Ernst von Dobschuetz,
    • Claudio Letizia,
    • Gerlof Valk,
    • Marcin Barczynski,
    • Malgorzata Czetwertynska,
    • John T M Plukker,
    • Paola Sartorato,
    • Tomas Zelinka,
    • Petr Vlcek,
    • Svetlana Yaremchuk,
    • Georges Weryha,
    • Letizia Canu,
    • Nelson Wohllk,
    • Frederic Sebag,
    • Martin K Walz,
    • Charis Eng,
    • and Hartmut P H Neumann

    The penetrance of MEN2 pheochromocytoma is not only determined by RET mutations

    Endocr Relat Cancer 24 (8) L63-L67, doi:10.1530/ERC-17-0189 first published on 25 June 2017

Letter to the Editor

    • Ruth T Casey,
    • Benjamin G Challis,
    • Alison Marker,
    • Deborah Pitfield,
    • Heok K Cheow,
    • Ashley Shaw,
    • Soo-Mi Park,
    • Helen L Simpson,
    • and Eamonn R Maher

    A case of a metastatic SDHA mutated paraganglioma re-presenting twenty-three years after initial surgery

    Endocr Relat Cancer 24 (8) L69-L71, doi:10.1530/ERC-17-0206
    OPEN ACCESS ARTICLE

This Issue

August 2017; 24 (8)
Cover
  1. Review
  2. Research
  3. Research Letter
  4. Letter to the Editor

Find articles in this issue containing these words:

New Articles: issue in progress

  1. August 2017, 24 (8)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most